{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:52:21Z","timestamp":1790790741419,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T00:00:00Z","timestamp":1587254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T00:00:00Z","timestamp":1587254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gram-positive spectrum antibiotics such as vancomycin, teicoplanin, daptomycin, and linezolid are frequently used in empirical treatment combinations in critically ill patients. Such inappropriate and unnecessary widespread use, leads to sub-optimal utilisation. However they are covered by the antibiotics restriction programme. This prospective observational study, evaluates gram-positive anti-bacterial utilisations in intensive care units (ICUs) with various evaluation criteria, to determine the frequency of inappropriate usage and the intervention targets required to ensure optimum use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This clinical study was conducted prospectively between 01.10.2018 and 01.10.2019 in the medical and surgical ICUs of Gazi University Faculty of Medicine Hospital, Turkey. The total bed capacity was 55. Patients older than 18\u2009years and who were prescribed gram-positive spectrum antibiotics (vancomycin, teicoplanin, linezolid, and daptomycin) were included. Patients under this age or immunosuppressed patients (neutropenic,- HIV-infected patients with hematologic or solid organ malignancies) were not included in the study. During the study period, 200 treatments were evaluated in 169 patients. The demographic and clinical features of the patients were recorded. Besides observations by the clinical staff, the treatments were recorded and evaluated by two infectious diseases specialists and two clinical pharmacists at 24-h intervals from the first day to the last day of treatment.<\/jats:p>\n                    <jats:p>SPSS software for Windows, (version 17, IBM, Armonk, NY) was used to analyse the data. Categorical variables were presented as number and percentage, and non-categorical variables were presented as mean\u2009\u00b1\u2009standard deviation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>It was found that inappropriate gram-positive antibiotic use in ICUs was as high as 83% in terms of non-compliance with the selected quality parameters. Multivariate analysis was performed to evaluate the factors associated with inappropriate antibiotic use, increased creatinine levels were found to increase the risk of such use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In spite of the restricted antibiotics programme, inappropriate antibiotic use in ICUs is quite common. Thus, it is necessary to establish local guidelines in collaboration with different disciplines for the determination and follow-up of de-escalation of such use and optimal treatment doses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05005-7","type":"journal-article","created":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T10:02:33Z","timestamp":1587290553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Inapropriate use of antibiotics effective against gram positive microorganisms despite restrictive antibiotic policies in ICUs: a prospective observational study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1154-5850","authenticated-orcid":false,"given":"Hasan Sel\u00e7uk","family":"\u00d6zger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8376-1328","authenticated-orcid":false,"given":"Dolunay Merve","family":"Fak\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5138-9210","authenticated-orcid":false,"given":"K\u00fcbra","family":"Erbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5862-4746","authenticated-orcid":false,"given":"Asl\u0131nur","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8644-139X","authenticated-orcid":false,"given":"Kenan","family":"H\u0131zel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,19]]},"reference":[{"issue":"11","key":"5005_CR1","doi-asserted-by":"publisher","first-page":"e0207991","DOI":"10.1371\/journal.pone.0207991","volume":"13","author":"MC Kallen","year":"2018","unstructured":"Kallen MC, Roos-Blom MJ, Dongelmans DA, Schouten JA, Gude WT, de Jonge E, Prins JM, de Keizer NF. Development of actionable quality indicators and an action implementation toolbox for appropriate antibiotic use at intensive care units: a modified-RAND Delphi study. PLoS One. 2018;13(11):e0207991.","journal-title":"PLoS One"},{"issue":"1","key":"5005_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1120009X.2016.1156893","volume":"29","author":"E Guclu","year":"2017","unstructured":"Guclu E, Ogutlu A, Karabay O, Demirdal T, Erayman I, Hosoglu S, Turhan V, Erol S, Oztoprak N, Batirel A. Antibiotic consumption in Turkish hospitals; a multi-Centre point prevalence study. J Chemother. 2017;29(1):19\u201324.","journal-title":"J Chemother"},{"issue":"7","key":"5005_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S1473-3099(16)00065-7","volume":"16","author":"EC Schuts","year":"2016","unstructured":"Schuts EC, Hulscher ME, Mouton JW, Verduin CM, Stuart JWC, Overdiek HW, van der Linden PD, Natsch S, Hertogh CM, Wolfs TF. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. The Lancet Infect Dis. 2016;16(7):847\u201356.","journal-title":"The Lancet Infect Dis"},{"issue":"1","key":"5005_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13054-015-0795-y","volume":"19","author":"K Marquet","year":"2015","unstructured":"Marquet K, Liesenborgs A, Bergs J, Vleugels A, Claes N. Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis. Crit Care. 2015;19(1):63.","journal-title":"Crit Care"},{"issue":"5","key":"5005_CR5","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s13054-014-0480-6","volume":"18","author":"C-E Luyt","year":"2014","unstructured":"Luyt C-E, Br\u00e9chot N, Trouillet J-L, Chastre J. Antibiotic stewardship in the intensive care unit. Crit Care. 2014;18(5):480.","journal-title":"Crit Care"},{"issue":"2","key":"5005_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/cid\/ciu747","volume":"60","author":"CM van den Bosch","year":"2014","unstructured":"van den Bosch CM, Geerlings SE, Natsch S, Prins JM, Hulscher ME. Quality indicators to measure appropriate antibiotic use in hospitalized adults. Clin Infect Dis. 2014;60(2):281\u201391.","journal-title":"Clin Infect Dis"},{"key":"5005_CR7","unstructured":"Scott CL, Brown E, Charani E, Michie S, Ramsay CR, Marwick CA, Davey P. Interventions to improve antibiotic prescribing practices for hospital inpatients (updated protocol). Cochrane Database Syst Rev. 2017;2017(2):28\u201330."},{"issue":"10","key":"5005_CR8","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/cid\/ciw118","volume":"62","author":"TF Barlam","year":"2016","unstructured":"Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51\u201377.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"5005_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ajic.2017.08.038","volume":"46","author":"A Molayi","year":"2018","unstructured":"Molayi A, Kirk A, Markley J, Bernard S, Taylor P, Sanogo K, Lee K, Pakyz A, Doll M, Bearman G. Description of a restriction program for gram-positive antimicrobial agents at an academic medical center. Am J Infect Control. 2018;46(2):232\u20134.","journal-title":"Am J Infect Control"},{"issue":"1","key":"5005_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.chest.2018.10.014","volume":"155","author":"MC Cowley","year":"2019","unstructured":"Cowley MC, Ritchie DJ, Hampton N, Kollef MH, Micek ST. Outcomes associated with de-escalating therapy for methicillin-resistant Staphylococcus aureus in culture-negative nosocomial pneumonia. Chest. 2019;155(1):53\u20139.","journal-title":"Chest"},{"issue":"1","key":"5005_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/jac\/dkx341","volume":"73","author":"LD Dresser","year":"2017","unstructured":"Dresser LD, Bell CM, Steinberg M, Ferguson ND, Lapinsky S, Lazar N, Murphy P, Singh JM, Morris AM. Use of a structured panel process to define antimicrobial prescribing appropriateness in critical care. J Antimicrob Chemother. 2017;73(1):246\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"5005_CR12","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1128\/AAC.00627-10","volume":"54","author":"M Paul","year":"2010","unstructured":"Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010;54(11):4851\u201363.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"5005_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ijantimicag.2009.07.006","volume":"34","author":"A Erbay","year":"2009","unstructured":"Erbay A, \u0130dil A, G\u00f6zel MG, Mumcuo\u011flu \u0130, Balaban N. Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections. Int J Antimicrob Agents. 2009;34(6):575\u20139.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"5005_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5152\/TurkPediatriArs.2018.5644","volume":"53","author":"AB Erg\u00fcl","year":"2018","unstructured":"Erg\u00fcl AB, G\u00f6k\u00e7ek \u0130, \u00c7elik T, Torun YA. Assessment of inappropriate antibiotic use in pediatric patients: point-prevalence study. Turk Pediatr Arsivi. 2018;53(1):17.","journal-title":"Turk Pediatr Arsivi"},{"key":"5005_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijid.2019.02.044","volume":"82","author":"BE \u015eengel","year":"2019","unstructured":"\u015eengel BE, Bilgin H, Bilgin B\u00d6, Gidener T, Saydam S, Pekmezci A, Erg\u00f6n\u00fcl \u00d6, Korten V. The need for an antibiotic stewardship program in a hospital using a computerized pre-authorization system. Int J Infect Dis. 2019;82:40\u20133.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"5005_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.7150\/ijms.8.339","volume":"8","author":"A Altunsoy","year":"2011","unstructured":"Altunsoy A, Aypak C, Azap A, Erg\u00f6n\u00fcl \u00d6, Bal\u0131k \u0130. The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey. Int J Med Sci. 2011;8(4):339.","journal-title":"Int J Med Sci"},{"issue":"4","key":"5005_CR17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ijantimicag.2018.12.001","volume":"53","author":"S Abbara","year":"2019","unstructured":"Abbara S, Pitsch A, Jochmans S, Hodjat K, Cherrier P, Monchi M, Vinsonneau C, Diamantis S. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit. Int J Antimicrob Agents. 2019;53(4):416\u201322.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"5005_CR18","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00134-016-4301-z","volume":"42","author":"L De Bus","year":"2016","unstructured":"De Bus L, Denys W, Catteeuw J, Gadeyne B, Vermeulen K, Boelens J, Claeys G, De Waele JJ, Decruyenaere J, Depuydt PO. Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study. Intensive Care Med. 2016;42(6):1029\u201339.","journal-title":"Intensive Care Med"},{"issue":"1","key":"5005_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13054-016-1267-8","volume":"20","author":"P Montravers","year":"2016","unstructured":"Montravers P, Augustin P, Grall N, Desmard M, Allou N, Marmuse J-P, Guglielminotti J. Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections. Crit Care. 2016;20(1):83.","journal-title":"Crit Care"},{"issue":"1","key":"5005_CR20","first-page":"41","volume":"55","author":"B Arda","year":"2007","unstructured":"Arda B, Sipahi OR, Yamazhan T, Tasbakan M, Pullukcu H, Tunger A, Buke C, Ulusoy S. Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance. J Inf Secur. 2007;55(1):41\u20138.","journal-title":"J Inf Secur"},{"issue":"1","key":"5005_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijantimicag.2017.06.020","volume":"51","author":"NT Mutters","year":"2018","unstructured":"Mutters NT, De Angelis G, Restuccia G, Di Muzio F, Schouten J, Hulscher M, Antonelli M, Tacconelli E. Use of evidence-based recommendations in an antibiotic care bundle for the intensive care unit. Int J Antimicrob Agents. 2018;51(1):65\u201370.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"5005_CR22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/jac\/dkv349","volume":"71","author":"C Roger","year":"2015","unstructured":"Roger C, Muller L, Wallis S, Louart B, Saissi G, Lipman J, Lefrant J, Roberts J. Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltration. J Antimicrob Chemother. 2015;71(2):464\u201370.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"5005_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ijantimicag.2018.03.008","volume":"52","author":"A Soraluce","year":"2018","unstructured":"Soraluce A, As\u00edn-Prieto E, Rodr\u00edguez-Gasc\u00f3n A, Barrasa H, Maynar J, Carcelero E, Soy D, Isla A. Population pharmacokinetics of daptomycin in critically ill patients. Int J Antimicrob Agents. 2018;52(2):158\u201365.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"5005_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijantimicag.2018.03.001","volume":"52","author":"CJ Economou","year":"2018","unstructured":"Economou CJ, Kielstein JT, Czock D, Xie J, Field J, Richards B, Tallott M, Visser A, Koenig C, Hafer C. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy. Int J Antimicrob Agents. 2018;52(2):151\u20137.","journal-title":"Int J Antimicrob Agents"},{"key":"5005_CR25","doi-asserted-by":"crossref","unstructured":"Leone M, Roberts JA, Bassetti M, Bougl\u00e9 A, Lavigne J-P, Legrand M, Neely M, Paiva J-A, Payen D, Rello J. Update in antibiotic therapy in intensive care unit: report from the 2019 N\u00eemes International Symposium. Anaesth Cr\u0131t Care Pain Med. 2019;38:12\u201313.","DOI":"10.1016\/j.accpm.2019.09.009"},{"issue":"n\u00fam 8","key":"5005_CR26","first-page":"1","volume":"58","author":"J Rello Condomines","year":"2014","unstructured":"Rello Condomines J. DALI defining antibiotic levels in intensive care unit patients are current beta-lactam antibiotic doses sufficient for critically ill patients. Clin Infect Dis. 2014;58(n\u00fam 8):1\u20131072-83.2014.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05005-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05005-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05005-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T19:04:33Z","timestamp":1618772673000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05005-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,19]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5005"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05005-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.21842\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21842\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21842\/v3","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,19]]},"assertion":[{"value":"24 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of Gazi University School of Medicine, Ankara\/ (Turkey) and was conducted according to the Declaration of Helsinki and Good Clinical Practice. (No:02\/14.01.2019). Written informed consent was obtained from the adult (>\u200918\u2009years old) patients who participated in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"289"}}